NEW YORK / RankWire.AI / – Global health authorities utilized a gathering at the UN General Assembly to promote the adoption of artificial intelligence in disease elimination, emphasizing that countries should lead these efforts. The event assembled ministers, public health experts, funders, and diagnostics specialists. Co-hosted by the Global Institute for Disease Elimination, known as GLIDE, and the RBM Partnership to End Malaria along with Nigeria, the discussions centered on disease monitoring, health system planning, resource distribution, and the prerequisites for responsible AI deployment.

Participants highlighted that governments must steer decisions on how health systems incorporate and oversee AI technology. Michael Adekunle Charles, CEO of the RBM Partnership to End Malaria, spoke on behalf of Nigeria’s health minister, Muhammad Ali Pate. Nigeria continues to advance its Health Sector Renewal Investment Initiative, which covers primary healthcare, health financing, workforce enhancement, and improved data systems. The gathering also underscored the importance of aligning new technological solutions with existing national health priorities.
The discussions addressed the practical requirements for expanding AI integration within disease control initiatives. Reliable data, trained healthcare personnel, sustainable financial resources, and seamless system integration were identified as critical factors. Malaria remains a primary concern for global health organizations. The World Health Organization’s estimates indicate that there were 282 million malaria cases worldwide in 2024, resulting in 610,000 deaths. The WHO African Region bore the majority of this burden, with Nigeria recording the highest estimated number of malaria cases.
New AI initiatives focus on strengthening health leadership skills
GLIDE announced two new training programs aimed at enhancing public health leaders’ knowledge of artificial intelligence. Its GLIDE Leadership Excellence in AI for Health program will welcome senior decision-makers to Abu Dhabi from January 17 to 22, 2027. The first residential cohort is expected to include 25 to 30 participants. Training will encompass AI governance, organizational readiness, deployment strategies, and accountability measures. The course is designed for officials responsible for health policy and national disease programs.
Mohamed bin Zayed University of Artificial Intelligence partnered with GLIDE to develop a second initiative, AI for All, which targets public health professionals through an online course. The program features four modules, does not require coding skills, and covers core AI concepts, generative AI, biases, privacy issues, accountability, and human oversight. The curriculum provides health practitioners with foundational knowledge to evaluate AI tools used in public health. It also offers guidance on assessing technologies before integrating them into routine operations.
Partnerships deepen technical collaboration on malaria
During the New York meeting, GLIDE and the RBM Partnership to End Malaria signed a letter of mutual understanding. This agreement aims to combine technical expertise, innovative approaches, and capacity-building efforts aligned with national malaria priorities. It promotes country-led malaria control and elimination initiatives. The collaboration also supports the World Health Organization’s Global Technical Strategy for Malaria, which aims to cut malaria cases and fatalities through 2030 while strengthening surveillance and health systems.
The broader dialogue included discussions on polio and neglected tropical diseases alongside malaria. Attendees examined how AI can assist in surveillance, enhance program decision-making, and optimize resource utilization. Emphasizing national health authorities’ central role, the event also highlighted the importance of training and institutional capacity as countries explore new digital tools. The initiatives unveiled in New York linked AI education, technical collaboration, and national leadership to ongoing efforts to eliminate preventable infectious diseases.
